National
Santorum drops out of 2012 race
Advocates happy to see anti-gay candidate go
Republican presidential candidate Rick Santorum has dropped his bid for the White House(photo via Iowapolitics.com via wikimedia)
Rick Santorum announced on Tuesday he would no longer pursue the Republican nomination for the White House, ending the campaign of one of the most anti-gay candidates seeking the presidency.
During a speech in Gettysburg, Pa., the former U.S. senator announced he decided to suspend his campaign after taking a break to care for his three-year-old daughter who was hospitalized over the weekend.
“We made a decision to get into this race at our kitchen table against all the odds, and we made a decision over the weekend that while this presidential race, for us, is over for me, and we will suspend our campaign effective today, we are not done fighting,” Santorum said.
The departing candidate took no questions after he gave his exit speech, nor did he endorse another candidate.
Santorum, who represented Pennsylvania in the U.S. Senate from 1995 to 2006, won 11 states and earned 285 delegates, the second highest of all the presidential candidates behind Mitt Romney.
The candidate’s exit comes before the primary took place in his home state of Pennsylvania on April 24. Polls showed Santorum was narrowly ahead in the race. According to a Rasmussen poll published on Thursday, 42 percent of likely voters are supporting Santorum, while 38 percent of likely voters support Romney.
Many observers had already declared the primary season over. Romney appeared to be the frontrunner for the GOP nomination after winning three primaries in Wisconsin, D.C. and Maryland. Romney had also amassed 661 delegates, which is more than the other Republican candidates combined.
Dan Pinello, who’s gay and a government professor at City University of New York, said he doesn’t think Santorum’s departure “seriously affects the race” and the candidate exited because his money dried up.
“Romney was spending $2 million in the Pennsylvania primary alone, and Santorum had nothing to fight back with,” Pinello said. “Plus, all the endorsements of party insiders were going to Romney. Better to bow out than be humiliated in your own home state.”
In the past couple weeks, Romney secured endorsements from Sen. Marco Rubio (R-Fla.) and House Budget Committee Chair Paul Ryan (R-Wis.) — both seen as rising stars within the Republican Party.
Santorum had taken many anti-gay positions over the course of his campaign and backed a Federal Marriage Amendment barring same-sex marriage throughout the country.
Last year, Santorum was among the GOP hopefuls who signed a pledge from the anti-gay National Organization for Marriage committing himself to backing a Federal Marriage Amendment, defending the Defense of Marriage Act in court, and establishing a commission on “religious liberty” to investigate the alleged harassment of same-sex marriage opponents.
Santorum also said he would reinstate “Don’t Ask, Don’t Tell” if elected to the White House, pledging in a public forum to the anti-gay Family Research Council’s Tony Perkins in March to reverse repeal of the military’s gay ban.
“I don’t believe [open service is] in the best interest of our men and women in uniform,” Santorum said. “That doesn’t mean that people who are gay and lesbian can’t serve, it’s just that they can serve in the context of what, I think, everybody in the military does — keep their own private matters to themselves and serve this country accordingly.”
When “Don’t Ask, Don’t Tell” was in effect from 1994 to 2011, an estimated 14,346 service members were expelled from the military. Many of those troops were expelled even though they made no declaration about their sexual orientation.
FRC’s Perkins praised Santorum upon his exit from the race, saying he carried a “message of faith, family and freedom” over the course of the campaign.
“Millions of voters flocked to Rick not because he was a Republican, but because he passionately articulated the connection between America’s financial greatness and its moral and cultural wholeness,” Perkins said. “He realizes that real problem-solving starts with an understanding that the economy and the family are indivisible.”
Perkins and other evangelicals were among the nearly 170 anti-gay leaders who rallied behind Santorum in January at a conference in Brenham, Texas, to discuss the GOP primary race and top policy goals for a Republican administration.
Santorum became notorious for vocalizing his opposition to same-sex marriage throughout his campaign.
On the day Washington State legalized same-sex marriage on Feb. 13, Santorum traveled to the state and derided the news in a speech, urging opponents of the law to bring the law to a referendum before voters in November.
“There are ebbs and flows in every battle, and this is not the final word,” Santorum said before supporters in Olympia, Wash.
In the past year of campaigning, Santorum went as far as saying “our country will fail” as a result of same-sex marriage and raised eyebrows in August when he said same-sex marriage is like “saying this glass of water is a glass of beer.”
In January, Santorum drew fire for vocalizing his opposition to same-sex marriage when campaigning in the libertarian state of New Hampshire, which has legalized same-sex marriage.
“Marriage is a privilege,” Santorum said. “It is not a right. It is privilege given by society, held up by society, for purposes that it provides some societal good, and I would make the argument, some extraordinary societal good.”
Prior to his final campaign appearance in New Hampshire on Jan. 10, protesters from the Occupy movement jeered Santorum, chanting “Bi-got! Bi-got! Bi-got!”
After the Ninth Circuit Court of Appeals on Feb. 8 ruled against California’s Proposition 8, Santorum railed against the decision.
“The Ninth Circuit decision yesterday said that marriage, if you believe in traditional marriage, between a man and a woman and exclusively that, you are in fact, the only reason you could possibly believe that, is because you are a bigot,” Santorum said. “Your belief of marriage between a man and a woman is purely irrational based on hatred and bigotry.”
It’s this kind of anti-gay rhetoric that made LGBT advocates happy to see Santorum exit the race.
Jerame Davis, executive director of the National Stonewall Democrats, said the anti-gay positions that Santorum staked out during his campaign made him “a stain on the Republican Party,” but predicted the candidate wouldn’t vanish from public view now that he’s departed the race.
“It was always clear that Santorum was not going to be the GOP nominee, but unfortunately we haven’t seen the last of him,” Davis said. “His brand of ultra-conservatism and rank piety appealed to a particular slice of the Republican electorate.”
R. Clarke Cooper, executive director of the Log Cabin Republicans, had a more positive spin on Santorum’s departure, saying the end of his anti-gay rhetoric would enable the GOP to appeal to a broader constituency as Election Day draws closer.
“The departure of Rick Santorum’s divisive social politics from the race puts moderate, independent and younger conservative voters in play,” Cooper said. “The time is now for the Republican Party to capitalize by presenting an inclusive, united front focused on economic growth, exploration of natural resources and defending national interests abroad.”
Advocates said Santorum’s exit reinforces the notion that LGBT people should be prepared for Romney to become the Republican presidential nominee — whether they support his candidacy or not.
Jimmy LaSalvia, executive director of GOProud, said Romney had already sealed the nomination even before Santorum dropped out of the race. LaSalvia has personally endorsed Romney’s candidacy.
“Rick Santorum has recognized the political reality that most in the party have acknowledged for weeks now – Mitt Romney will be the nominee of the Republican Party,” LaSalvia said.
Michael Cole-Schwartz, a spokesperson for the Human Rights Campaign, said Santorum’s exit means the LGBT community needs only to focus on Romney’s anti-gay positions.
“We now go from two leading candidates that would take LGBT rights completely backward in this country to one candidate who’d do the same,” Cole-Schwartz said. “While we might not be faced with Sen. Santorum’s extreme rhetoric anymore, we’re left with Gov. Romney whose anti-LGBT positions aren’t substantively much different.”
Romney has signed the same anti-gay pledge from NOM and has criticized Obama for dropping the government’s defense of the Defense of Marriage Act in court. Still, the GOP frontrunner has said he doesn’t think the political wherewithal will be present in Congress to pass a Federal Marriage Amendment, and he has no plans to return to “Don’t Ask, Don’t Tell.”
Santorum’s departure means that only two Republican candidates other than Romney remain in the race: Rep. Ron Paul (R-Texas) and former U.S. House Speaker Newt Gingrich. But Paul hasn’t won any states in the primaries, and Gingrich’s campaign has all but run out of gas.
Obama appears to be leading Romney as the primary season comes to an end. According to a Washington Post-ABC News poll published Tuesday, registered voters favored Obama by 51 percent, while 44 percent were behind Romney.
NOTE: This post has been updated.
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
The White House
EXCLUSIVE: Democracy Forward files FOIA lawsuit after HHS deadnames Rachel Levine
Trans former assistant health secretary’s name changed on official portrait
Democracy Forward, a national legal organization that works to advance democracy and social progress through litigation, policy and public education, and regulatory engagement, filed a lawsuit Friday in federal court seeking to compel the U.S. Department of Health and Human Services to release information related to the alteration of former Assistant Secretary for Health Adm. Rachel Levine’s official portrait caption.
The lawsuit comes in response to the slow pace of HHS’s handling of multiple Freedom of Information Act requests — requests that federal law requires agencies to respond to within 20 working days. While responses can take longer due to backlogs, high request volumes, or the need for extensive searches or consultations, Democracy Forward says HHS has failed to provide any substantive response.
Democracy Forward’s four unanswered FOIA requests, and the subsequent lawsuit against HHS, come days after someone in the Trump-Vance administration changed Levine’s official portrait in the Hubert H. Humphrey Building to display her deadname — the name she used before transitioning and has not used since 2011.
According to Democracy Forward, HHS “refused to release any records related to its morally wrong and offensive effort to alter former Assistant Secretary for Health Admiral Rachel Levine’s official portrait caption.” Levine was the highest-ranking openly transgender government official in U.S. history and served as assistant secretary for health and as an admiral in the U.S. Public Health Service Commissioned Corps from 2021 to 2025.
Democracy Forward President Skye Perryman spoke about the need to hold the Trump-Vance administration accountable for every official action, especially those that harm some of the most targeted Americans, including trans people.
“The question every American should be asking remains: what is the Trump-Vance administration hiding? For an administration that touts its anti-transgender animus and behavior so publicly, its stonewalling and silence when it comes to the people’s right to see public records about who was behind this decision is deafening,” Perryman said.
“The government’s obligation of transparency doesn’t disappear because the information sought relates to a trailblazing former federal official who is transgender. It’s not complicated — the public is entitled to know who is making decisions — especially decisions that seek to alter facts and reality, erase the identity of a person, and affect the nation’s commitment to civil rights and human dignity.”
“HHS’s refusal to respond to these lawful requests raises more serious concerns about transparency and accountability,” Perryman added. “The public has every right to demand answers — to know who is behind this hateful act — and we are going to court to get them.”
The lawsuit also raises questions about whether the alteration violated federal accuracy and privacy requirements governing Levine’s name, and whether the agency improperly classified the change as an “excepted activity” during a lapse in appropriations. By failing to make any determination or produce any records, Democracy Forward argues, HHS has violated its obligations under federal law.
The case, Democracy Forward Foundation v. U.S. Department of Health and Human Services, was filed in the U.S. District Court for the District of Columbia. The legal team includes Anisha Hindocha, Daniel McGrath, and Robin Thurston.
The Washington Blade reached out to HHS, but has not received any comment.
The lawsuit and four FOIA requests are below:
Long-awaited ‘Pillion’ surpasses the sexy buzz
Trump’s ‘American people derangement syndrome’
Reasons to be optimistic about 2026
Using movement to boost your mental health during holidays
Protecting the trans community is not optional for elected allies and candidates
Reasons to be optimistic about 2026
America is going in the wrong direction for intersex children
Rush reopens after renewing suspended liquor license
Long-awaited ‘Pillion’ surpasses the sexy buzz
